Literature DB >> 1341261

K-ras gene mutations in adenomas and carcinomas of the colon.

I S Boughdady1, A R Kinsella, N Y Haboubi, P F Schofield.   

Abstract

DNA extracted from 29 colorectal carcinomas and 40 sporadic adenomas was amplified by the polymerase chain reaction (PCR) and analysed for the presence of K-ras gene mutations at codon 12 using a panel of synthetic oligonucleotide probes specific for normal and mutated sequences. The presence of mutations was correlated with various histopathological and clinical data. Ten carcinomas (34.5%) and 14 sporadic adenomas (35%) showed K-ras mutations at codon 12. In the carcinoma group, no apparent correlation was found between the presence of mutant oncogenes and the degree of histological differentiation, Dukes' staging or the development of distant metastasis. In the adenoma group, the frequency of mutations increased with the size of the adenoma and the severity of the dysplastic changes. This study confirms that ras gene mutations are common and early events in colon carcinogenesis. They appear to give a selective growth advantage to those polyps with mutations which leads to their increase in size and thus possibly prepare the ground for malignant transformation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1341261     DOI: 10.1016/0960-7404(92)90088-3

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  18 in total

1.  KRAS polymorphisms are associated with survival of CRC in Chinese population.

Authors:  Qiong Dai; Hui Lian Wei; Juan Huang; Tie Jun Zhou; Li Chai; Zhi-Hui Yang
Journal:  Tumour Biol       Date:  2015-10-29

2.  Homeobox protein CDX2 reduces Cox-2 transcription by inactivating the DNA-binding capacity of nuclear factor-kappaB.

Authors:  Hiroyuki Mutoh; Hiroko Hayakawa; Hirotsugu Sakamoto; Kentaro Sugano
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

3.  Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study.

Authors:  Adam Naguib; Panagiota N Mitrou; Laura J Gay; James C Cooke; Robert N Luben; Richard Y Ball; Alison McTaggart; Mark J Arends; Sheila A Rodwell
Journal:  BMC Cancer       Date:  2010-03-16       Impact factor: 4.430

Review 4.  The treatment of colorectal carcinoma with monoclonal antibodies: the importance of KRAS mutation analysis and EGFR status.

Authors:  Sebastian Stintzing; Volker Heinemann; Nicolas Moosmann; Wolfgang Hiddemann; Andreas Jung; Thomas Kirchner
Journal:  Dtsch Arztebl Int       Date:  2009-03-20       Impact factor: 5.594

5.  Infrequent K-ras codon 12 mutation in serrated adenomas of human colorectum.

Authors:  Y Ajioka; H Watanabe; J R Jass; Y Yokota; M Kobayashi; K Nishikura
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

6.  Oxaliplatin-based Chemotherapy Might Provide Longer Progression-Free Survival in KRAS Mutant Metastatic Colorectal Cancer.

Authors:  Yu-Lin Lin; Jau-Yu Liau; Shan-Chi Yu; Li-Hui Tseng; Liang-In Lin; Jin-Tung Liang; Ben-Ren Lin; Ji-Shiang Hung; Yih-Leong Chang; Kun-Huei Yeh; Ann-Lii Cheng
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

7.  Sensitive detection of KRAS mutations in archived formalin-fixed paraffin-embedded tissue using mutant-enriched PCR and reverse-hybridization.

Authors:  Christoph Ausch; Veronika Buxhofer-Ausch; Christian Oberkanins; Barbara Holzer; Michael Minai-Pour; Stephan Jahn; Nadia Dandachi; Robert Zeillinger; Gernot Kriegshäuser
Journal:  J Mol Diagn       Date:  2009-10-01       Impact factor: 5.568

8.  A let-7 KRAS rs712 polymorphism increases colorectal cancer risk.

Authors:  Xin-Min Pan; Rui-Fen Sun; Zhao-Hui Li; Xiao-Min Guo; Zhen Zhang; Hao-Jie Qin; Guo-Hui Xu; Lin-Bo Gao
Journal:  Tumour Biol       Date:  2013-08-24

9.  Expression of Epidermal Growth Factor Receptor Detected by Cetuximab Indicates Its Efficacy to Inhibit In Vitro and In Vivo Proliferation of Colorectal Cancer Cells.

Authors:  Kohei Shigeta; Tetsu Hayashida; Yoshinori Hoshino; Koji Okabayashi; Takashi Endo; Yoshiyuki Ishii; Hirotoshi Hasegawa; Yuko Kitagawa
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

10.  Molecular detection (k-ras) of exfoliated tumour cells in the pelvis is a prognostic factor after resection of rectal cancer?

Authors:  Annette Torgunrud Kristensen; Johan N Wiig; Stein G Larsen; Karl-Erik Giercksky; Per O Ekstrøm
Journal:  BMC Cancer       Date:  2008-07-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.